Effects of caveolin-1 on the 17beta-estradiol-mediated inhibition of VSMC proliferation induced by vascular injury

Estrogen has a protective effect on the cardiovascular system. Yet the mechanism of how estrogen inhibits vascular smooth muscle cell (VSMC) proliferation after vascular injury and the role of caveolin-1 in this process are not clear. To understand the protection effect of estrogen and caveolin-1, we employed a vascular balloon-injury model. Sixteen New Zealand White rabbits with or without estrogen were tested. 17beta-estradiol is able to inhibit VSMC proliferation in a range from 10(-10)-10(-5) mol/L, with an optimal concentration of 10(-8) mol/L. Estrogen exerted its effect through suppressing the activity of p42/44 MAPK, which can be blocked by tamoxifen. Moreover, in estrogen pretreated cells as well as in common carotid arteries of the balloon injury model, expression of caveolin-1 is enhanced compared to the estrogen-deficient group, as assessed by both western blotting and RT-PCR and morphological studies. Our results showed that the inhibition effect of estrogen in VSMCs is mediated by p42/44 MAPK. Caveolin-1 plays an important role in this protective process.     

葛根素对糖尿病致肺损伤的保护作用及其机制的研究

目的:探讨糖尿病对肺脏损伤及葛根素对肺组织影响的可能机制。方法:腹腔注射链脲佐菌素(STZ)建立大鼠糖尿病(DM)模型,SD大鼠随机分为对照组(C组)、糖尿病组(DM组)、糖尿病 葛根素组(DM Pur组)。检测注药前及模型成立后第20d、40d、60d的血糖及体重的改变。检测肺组织中一氧化氮(NO)和丙二醛(MDA)的含量、超氧化物歧化酶(SOD)活性。结合光镜、电镜、免疫组织化学染色方法综合评价。结果:①DM组NO、MDA高于C组(P<0.01),SOD活性低于C组(P<0.01),DM Pur组NO含量明显低于DM组(P<0.01),MDA含量40d开始显著降低(P<0.01),SOD活性高于DM组(P<0.01)。②光镜下见肺泡隔增厚,炎性细胞浸润;电镜下见Ⅱ型肺泡上皮细胞微绒毛数量明显减少,嗜锇性板层小体数量明显减少,细胞间质胶原纤维增生,葛根素可减轻肺组织上述病理性改变。③免疫组织化学染色结果:DM组细胞胞质中可见ONOO-特征性代表物硝基酪氨酸(ni-trotyrosine,NT)黄染阳性信号表达,且较对照组略为增强,DM Pur组黄染信号较DM组略为减弱。结论:①DM时可发生肺组织损伤,可能与长期高血糖诱导产生大量自由基有关。②NO/ONOO-通路是DM造成肺组织细胞损伤的机制之一。③初步证实葛根素能在一定程度上抑制高血糖诱导肺组织中自由基的过量生成,降低肺组织中的ONOO-的过度表达,这可能是其抗DM时肺组织损伤的作用机制之一。     

两种不同的静脉注射方法对血管的影响

目的：比较两种给药方法对血管损伤的程度。方法：采用自身对照法进行注射泵（实验组）和手推（对照组）静脉注射,指压止血,光镜下观察局部血管及周围组织的变化。结果：注射泵指压止血时间较短,静脉炎发生率低（P〈0.01）,差异具有高度显著性。结论：注射中血流动力学的改变可加重血管的损伤,使指压止血时间延长。     

丙酮酸钠对失血性休克大鼠缺血/再灌注损伤的保护作用

目的:研究丙酮酸钠对失血性休克后缺血/再灌注损伤的保护作用。方法:制作失血性休克大鼠模型,回输全血,同时分别给予生理盐水、谷胱甘肽和丙酮酸钠适量,于再灌注后3h处死动物。检测血浆乳酸脱氢酶(LDH)和谷草转氨酶(GOT)的活性、组织丙二醛(MDA)的含量和髓过氧化物酶(MPO)的活性,观察心、肝、肺和肾组织的病理变化。结果:丙酮酸钠组与生理盐水组相比,血浆LDH和GOT的活性降低,肝、肺和肾组织MDA的含量下降,心、肺和肾组织MPO活性降低,效果优于谷胱甘肽。心、肝、肺和肾组织形态学观察显示,丙酮酸钠使组织损伤减轻。结论:丙酮酸钠对失血性休克后再灌注损伤具有保护作用。其作用机制可能与清除氧自由基、减少中性粒细胞的浸润、减轻炎性反应有关。     

脊髓分级缺血再灌注损伤模型的建立与病理学评价

目的建立兔脊髓分级缺血再灌注损伤模型和探讨受伤脊髓病理变化可能机制。方法采用肾下腹主动脉阻断法,分别阻断腹主动脉30min、45min和60min后开放,再灌注48h观察神经功能变化以及病理学评价脊髓缺血再灌注损伤程度。结果脊髓缺血时间越长,后肢运动功能损害越明显。伤后2天发现受损脊髓出血、水肿、变性坏死,明显的白细胞浸润以及I-κBα、NF-κBp65、ICAM-l表达增加,脊髓灰质的病理损害严重。再灌注脊髓病理损伤程度依次为缺血60min组>缺血45min组>缺血30min组>假手术组。结论该模型是一种较好的脊髓缺血再灌注损伤模型,阻断肾下腹主动脉血流30min、45min、60min后开放可以较好地反应轻、中、重不同程度缺血再灌注损伤脊髓的病理变化特点。     

SPECT心肌灌注显像对急性心肌梗死患者PCI术后疗效评估

目的:探讨用单光子发射型计算机断层(single photon emission computedtomography,SPECT)心肌灌注显像,评估心肌梗死(AMI)经冠脉介入治疗(PCI)后的心肌灌注疗效。方法:采用99mTc-tetrofosmin(P53)SPECT心肌灌注显像对54例行PCI治疗的AMI患者评估心肌灌注情况,并追踪记录6个月内心脏事件发生率。结果:SPECT显示无复流组22例,有复流组32例,两组心肌梗死患者近期预后差异有统计学意义(P<0.05)。无复流组不良事件发生率较有复流组有增加趋势;另外,急诊PCI组的预后明显好于择期PCI组,差异有统计学意义(P<0.05)。结论:SPECT心肌灌注显像可对AMI患者梗死相关血管(IRA)再通治疗疗效进行可靠的无创性评价。     

细胞因子在ARDS发病机制中的作用

细胞因子是由多种细胞产生的多肽或低分子糖蛋白,在人体内含量极微,在pg水平就发挥作用。作为特异性免疫反应和非特异性免疫反应的蛋白质,细胞因子以自分泌、旁分泌、或内分泌方式产生,与相应的细胞表面受体结合,在局部或全身发挥复杂的生物学效应,它们的代谢异常和疾病的发生、发展有着密切的关系。有些细胞因子已应用于临床的生物学治疗,具有深远的临床应用价值,故对细胞因子的研究将是一个越来越重要的课题。急性肺损伤(ALI)/急性呼吸窘迫综合征(ARDS)发病机制错综复杂,大量临床和实验室研究证明多种效应细胞释放的炎症介质是造成ARDS的"中心环节",其中TNF-α、IL-1、IL-8、IL-10、CXC趋化因子等细胞因子在ARDS发病中的作用尤为重要。本文就细胞因子在ARDS发病机制中的作用做一综述。     

沙漠干热环境下猪腹部肠管火器伤后肝脏功能和形态的变化

目的:观察沙漠干热环境下猪腹部火器伤肠管穿透后肝脏功能和形态的变化。方法:沙漠干热环境组和常温环境组各健康长白仔猪42头随机等分为对照组和伤后1h、2h、4h、8h、12h和24h组,实验组建立腹部火器伤肠管穿透模型后,分别测定各组动物血清中AST水平,并与对照组比较。在光镜下观察各组肝脏组织学变化,电镜下观察肝脏超微结构改变。结果:伤后各组血清AST水平均高于对照组,并于伤后2h出现第1个高峰,沙漠干热环境组和常温环境组分别于伤后8h和12h出现第2个高峰。沙漠干热组和常温组分别于伤后4h和8h开始出现肝细胞的坏死和超微结构的明显变化。结论:沙漠干热环境下腹部肠管火器伤后肝脏结构和功能损伤的发生均较常温组提前,提示在沙漠干热环境下腹部火器伤更要及早对肝损伤采取相应的保护措施。     

Mechanisms of heat inactivation in Salmonella serotype Typhimurium as affected by low water activity at different temperatures

AIMS: To determine the effect of reduced water activity (a(w)) on thermal inactivation of Salmonella serotype Typhimurium at different temperatures and its mechanism. METHODS AND RESULTS: D-value determinations at a range of different temperatures showed that heating at reduced a(w) (0.94, produced by addition of glucose or sodium chloride to nutrient broth) was protective at temperatures above 53-55 degrees C but sensitizing below this temperature. Using selective enumeration media to determine injury, it was shown that at lower heating temperatures cells survived at high a(w) with cytoplasmic injury whereas at low a(w) these cells were killed. At higher temperatures ribosome degradation was a more important cause of death and was inhibited by low a(w) heating media thereby providing greater heat resistance. CONCLUSIONS: The observed change in behaviour reflects the different reactions responsible for thermal death at different temperatures and their different response to reduced a(w). SIGNIFICANCE AND IMPACT OF THE STUDY: This work qualifies the previous assumption that reduced a(w) is protective and suggests that the efficacy of low temperature pasteurization regimes may be increased by reduced a(w).     

Celecoxib after the onset of reperfusion reduces apoptosis in the amygdala

Reperfused myocardial infarction induces an inflammatory response that is responsible for local and systemic alterations. Among these, apoptosis observed in the amygdala following myocardial infarction has been pointed out as a consequence of such an inflammatory process. We hypothesized that inhibition of the inducible inflammatory enzyme Cox-2 during the reperfusion period may attenuate the apoptotic process in the amygdala. Anaesthetized rats were subjected to left anterior descending coronary artery occlusion for 40 min, followed by reperfusion. The Cox-2 antagonist Celecoxib (3 mg/kg i.p.) was administered 10 min after the onset of the reperfusion period. After 72 h of reperfusion, infarct size was determined and the lateral and medial amygdala were dissected from the brain. Infarct size was similar between untreated and Celecoxib-treated animals (40–45% of the area at risk). Cox-2 expression was significantly reduced in both parts of the amygdala in the Celecoxib group. Apoptosis regression was observed in the amygdala of the Celecoxib group as shown by decreased number of TUNEL positive cells and by decreased of caspase-3 activation. Bax/Bcl-2 ratio was not significantly altered by Celecoxib while Akt activation was increased in the lateral amygdala but not in the medial amygdala. This data indicates that inhibition of Cox-2 by Celecoxib is associated with regression of apoptosis in the amygdala following myocardial infarction.